Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells.
about
Tissue-Resident T Cells as the Central Paradigm of Chlamydia ImmunityA vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challengeUrethral cytokine and immune responses in Chlamydia trachomatis-infected males.Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaquesSimultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A.Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.Immunity to murine chlamydial genital infection.A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosaImmunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challengeCD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.Perforin is detrimental to controlling [corrected] C. muridarum replication in vitro, but not in vivo.Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity.Activation of the NLRP3 inflammasome by vault nanoparticles expressing a chlamydial epitope.Vaccination of koalas with a recombinant Chlamydia pecorum major outer membrane protein induces antibodies of different specificity compared to those following a natural live infectionMonitoring the T cell response to genital tract infection.Chlamydia trachomatis vaccine research through the years.Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge.A re-evaluation of the role of B cells in protective immunity to Chlamydia infectionDynamics of NKT-Cell Responses to Chlamydial Infection.Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cellsPlac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tractImmunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative CellsImmunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.A predominant role for antibody in acquired immunity to chlamydial genital tract reinfectionProteomic identification of immunodominant chlamydial antigens in a mouse modelVaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models.Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatisAntigen-induced immunomodulation in the pathogenesis of atherosclerosis.IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.
P2860
Q28075820-4B699BE6-ADC4-4253-9572-D904D9BD94D6Q28391567-858D001F-0DFF-4CFF-8AED-FC096A20467CQ33554451-BFF04858-9C6C-4CD7-AA78-09C474CDA4A2Q33588632-7D5403B9-F3AC-4749-BC04-A2108EB98E51Q33620511-CAADDF5D-D93D-4DCD-9833-626E1D16FC73Q33694896-1C285CA6-0A8B-4429-8C63-D34FF585A793Q34034089-3D3BB952-B581-4D8B-981F-FE2E332972FBQ34119450-D8E1A4EC-185A-4FD6-B80D-02AA7D2C8714Q34119773-CF7D71F0-09D0-45B0-A559-A9FF9ED713DAQ34124225-137D5784-DC3B-412B-80DA-EE290D6FCBC6Q34129905-EDBE9AEB-B13D-4FC9-9BB0-627487CE6C50Q34130795-B99F9F1D-9788-4BA3-AADE-45F873E09C89Q34177368-8221CF17-10B9-47BE-945A-4542463AF674Q34194679-86E03AC5-A02E-4597-8E15-E20F2748544BQ34607259-DBBDD8BF-FB45-4D8A-AFE8-1B931F11F4CDQ34730267-75B2E1BF-7431-47B5-9D32-ED14F220F504Q34739969-57DCB631-071D-4B7E-8A5F-D4614A8B0E0EQ34743290-AEA69164-5AE7-48FC-8243-D9708077B1F7Q34749353-8850492A-9B4E-48F9-9AB0-85038DBEB761Q35005164-6DCB1126-68FF-4CD1-81CF-F0AD7AC458B7Q35033186-E329425A-CC06-48DA-9B1E-5492EB01B157Q35071155-8AC51E1E-1B4A-4533-8883-E695336E9801Q35113092-F7588C82-C609-4974-AB3B-5006A143E00BQ35214742-B455B7F7-D3E9-4000-9999-9A808BF3739CQ35471373-2FBB63ED-60D3-4012-8CCB-A91C87FDD07AQ35609500-A21AE54A-E93E-4892-8EB4-A42C4A320A99Q35689196-885C6C67-AD40-4CBA-B626-140BE8DF2D3EQ35828850-FCC31C4E-5314-426C-82A4-829B635F8339Q35829883-B3472650-D2A1-4199-9D3E-075E5EA6EFB3Q36027948-A78EA8A3-D522-421A-9CE5-C37FF2A95006Q36028197-3527801B-47D1-4BC0-9399-E10F42A8FA3BQ36211625-912CD550-6D7B-441D-A9B7-DEE056138976Q36445638-34A14C80-9324-4790-88DE-89209A5CA1F6Q36619644-745C7C1A-3885-4959-B767-C70A86641035Q36827004-5E0C4C10-1D7A-4FC9-A14C-96EF346C77C7Q36974443-396D0928-BF46-4F78-970D-9924E1B54D5DQ37087607-0C87E947-8BCB-4339-A5F7-65DAEC56CB53Q37159712-F3B2C1CB-4A49-46F3-9685-74B0AFDA6899Q37190468-308FA4C9-388A-4AC3-942F-E85E488BB31EQ37345928-B2EB6879-71CD-430E-845A-A516E0909E20
P2860
Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@ast
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@en
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@nl
type
label
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@ast
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@en
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@nl
prefLabel
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@ast
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@en
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@nl
P2860
P1476
Resolution of secondary Chlamy ...... of both CD4+ and CD8+ T cells.
@en
P2093
R P Morrison
S G Morrison
P2860
P304
P356
10.1128/IAI.69.4.2643-2649.2001
P407
P577
2001-04-01T00:00:00Z